PRESS RELEASES
June 26, 2025
Back in March, we saw the publication of our second health economic analysis of the cost-effectiveness of Ultrasound Renal Denervation (uRDN) for the treatment of resistant hypertensive patients.
June 26, 2025
Patients with uncontrolled high blood pressure saw meaningful reductions after switching to ultrasound renal denervation—even without increasing medications.
June 26, 2025
In this article, Professor Joachim Weil explores the pivotal role of patient empowerment in the context of renal denervation for treatment-resistant hypertension.
June 26, 2025
Prof. Roland Schmieder's study investigates the predictability of blood pressure reduction following renal denervation. The analysis shows a linear relationship between baseline blood pressure and the reduction: the higher the initial value, the greater the reduction.
May 16, 2025
World Hypertension Day’s Focus on High Blood Pressure Awareness, Management and Control Highlights Importance of New Therapies, like Ultrasound Renal Denervation.
March 11, 2025
Advancing Hypertension Management: Renal Denervation in clinical practice
March 11, 2025
Ultrasound Renal Denervation is now guideline-recommended: how do I get started?
March 11, 2025
Sleep disorders, particularly sleep apnea, pose a significant yet often overlooked threat to cardiovascular health. One of the most concerning impacts is their connection to high blood pressure (hypertension).
March 11, 2025
13 randomized sham-controlled trials (N=2,285) evaluated the efficacy and safety of ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rRDN). uRDN demonstrated a greater reduction in ambulatory SBP across all time points.
